NCT02403401 is a Phase 3 clinical trial of Levonorgestrel (BAY98-7196) in Contraception, sponsored by Bayer.

Who is sponsoring NCT02403401?

NCT02403401 is sponsored by Bayer.

What drugs are being tested in NCT02403401?

Interventions in NCT02403401: Levonorgestrel (BAY98-7196).

What condition does NCT02403401 study?

NCT02403401 studies Contraception.

Is NCT02403401 still recruiting?

NCT02403401 is currently completed. Last updated 8 April 2021.

Last reviewed 2021-04-08 · How we verify

NCT02403401

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women

Completed Phase 3 Last updated 8 April 2021

What this trial tests

Phase 3 trial testing Levonorgestrel (BAY98-7196) in Contraception in 1,471 participants. Completed in 7 July 2016.

Timeline

15 May 2015

Primary endpoint
7 July 2016

7 July 2016

Quick facts

Lead sponsor	Bayer
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	1,471
Start date	15 May 2015
Primary completion	7 July 2016
Estimated completion	7 July 2016
Sites	100 locations across Japan, United States

Drugs / interventions tested

Levonorgestrel (BAY98-7196) — full drug profile →

Conditions studied

Contraception — all drugs for Contraception →

Sponsor

Bayer — full company profile →

Who can join

Adults 18 to 35, female only, with Contraception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose of the study is to investigate safety and contraceptive efficacy of an LNG-containing intravaginal ring.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure.
Nave R, Höchel J, Mellinger U, Kohnke A, et al · · 2020 · PMID 32914172 · DOI 10.1093/humrep/deaa195

Verify or expand the search:

Other recruiting trials for Contraception

Currently open trials in the same condition.

NCT07365904 — Investigating Ovulation Inhibition for Use as a Contraceptive · Phase 2 · recruiting
NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
NCT06823037 — Hormonal Contraception Access Through Pharmacist Prescribing Implementation · NA · recruiting
NCT07326007 — Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women W · NA · recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting

Other Bayer trials

Trials by the same sponsor.

NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02403401 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayer
Last refreshed: 8 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02403401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing